Can Finasteride Cause Erectile Dysfunction? What the Latest Evidence Shows
Can finasteride cause erectile dysfunction? Yes, it can, though it is uncommon. A 2019 systematic review published in Acta Dermato-Venereologica pooled 15 randomised trials covering 4,495 men and found finasteride carried a 1.66 times higher risk of sexual dysfunction than placebo. For most men who develop it, the problem settles after stopping the drug.
Finasteride is a 5-alpha reductase inhibitor, or 5-ARI. It blocks the enzyme that converts testosterone into dihydrotestosterone, or DHT, the hormone that shrinks hair follicles in male pattern baldness. The 1 mg daily dose treats hair loss. A higher 5 mg dose treats an enlarged prostate and carries a greater chance of sexual side effects.
This article sets out what the research reports, how quickly symptoms settle after stopping, whether topical formulations differ, and why two studies from the same year point in opposite directions.
Quick Summary
Finasteride is a 5-alpha reductase inhibitor, or 5-ARI, that lowers DHT to slow hair loss.
Pooled data from 15 randomised trials give finasteride a relative risk of sexual dysfunction of 1.66, with a 95% confidence interval of 1.20 to 2.30.
That is an increase in risk, not a common outcome. Most men taking it report no sexual change at all.
When symptoms do appear, they usually settle within weeks to a few months of stopping.
A small group reports symptoms lasting far longer. Research can neither confirm nor rule this out as a distinct condition.
Finasteride raises circulating testosterone slightly rather than lowering it, so a normal testosterone result does not close the question.
Sudden or painful erection problems need assessment regardless of what medication you take.
Can finasteride cause erectile dysfunction?
Yes. Erectile dysfunction is the most frequently reported sexual side effect of finasteride, alongside reduced libido and changes in ejaculation. Regulators list it, the manufacturer lists it, and trial data support an increase over placebo.
What gets lost is the size of that increase. Reporting is often quoted as 1 to 2 percent of men at the hair-loss dose. That figure describes how many men reported a problem, not how much the drug raised the odds. The useful number compares the drug against placebo.
What the numbers say when patients ask: can finasteride cause erectile dysfunction
The pooled analysis is the clearest answer available. Across 15 randomised, placebo-controlled trials covering 4,495 men, 5-alpha reductase inhibitors carried a 1.57 times higher risk of sexual dysfunction. For finasteride the figure was 1.66, with a confidence interval of 1.20 to 2.30. Dutasteride showed 1.37, but that interval crossed 1, so the result was not significant.
A relative risk of 1.66 means the odds go up by roughly two thirds compared with placebo. It does not mean two thirds of men are affected. Starting from a low baseline, a two thirds increase still leaves most men with no sexual change at all.
How likely is it, and what the numbers actually say
Two things determine your individual risk, and neither is captured by a single percentage.
The first is dose. The 1 mg tablet taken for hair loss suppresses DHT less aggressively than the 5 mg tablet prescribed for prostate enlargement. Sexual side effects are reported more often at the higher dose.
The second is baseline. A man in his twenties with no vascular risk factors stands somewhere very different from a man in his fifties with untreated blood pressure or blood sugar. In the second man, finasteride is one candidate among several, and assuming it is the cause can delay finding the real one.
A 2026 propensity-matched cohort presented through the American Urological Association followed more than 10,000 men aged 18 to 45 and found raised erectile dysfunction risk at one and three years on the 1 mg dose. The AUA called for careful counselling, particularly in younger men. It is a conference abstract rather than a peer-reviewed paper, so read it as a signal, not settled proof. The AUA summary of that cohort sets it out.
How finasteride affects erections
An erection depends on blood flowing into the penis faster than it drains out, and on that inflow being held there. If you want the mechanics in detail, this piece on how an erection actually works covers them.
Finasteride does not act on that plumbing directly. It blocks 5-alpha reductase, so less testosterone converts into DHT. Circulating testosterone usually rises slightly as a result. That surprises people who assume the drug lowers testosterone, and it is why a normal testosterone result does not rule the question out.
DHT is active in nerve tissue and in the brain, not only in hair follicles and the prostate, and the same enzyme produces neuroactive steroids that influence mood and sexual response. Blocking it has effects beyond hair.
Even so, the precise pathway from DHT suppression to an erection problem is not established. Men born with a natural 5-alpha reductase deficiency do not show the pattern you would predict if DHT suppression alone explained it. Anyone who says the mechanism is settled is going beyond the evidence.
Key Takeaway
Finasteride lowers DHT, and DHT does more than shrink hair follicles. It is active in nerve tissue and in the brain, and the enzyme producing it also produces steroids that shape mood and sexual response. That is the most plausible route from a hair tablet to an erection problem. It is not proven, and the effect varies enormously between individuals.
Does it go away after stopping?
For most men, yes. This is the question that dominates online discussion, and it deserves a direct answer.
Finasteride clears the body within a day or two, though hormone levels take longer to settle. Reported recovery ranges from a few days to a few months, with most men improving within the first few weeks after stopping.
Trial data also show something less widely known. Sexual side effects resolved in many men who stayed on the drug rather than stopping it. That points to a degree of adaptation, and it is one reason a doctor may suggest a short period of review before you abandon a treatment that is working for your hair.
If three months have passed since stopping and nothing has improved, that is the point to stop waiting and get assessed. Persistent symptoms deserve investigation on their own terms, not simply attribution to a drug you no longer take.
Are the effects ever permanent?
A small number of men report sexual, mood and physical symptoms that continue for months or years after stopping. The term post-finasteride syndrome, or PFS, was created to describe this pattern.
A 2020 review published in Anais Brasileiros de Dermatologia examined the evidence and reached a deliberately careful conclusion: studies to date can neither refute nor confirm post-finasteride syndrome as a distinct clinical entity. If it does exist, it appears to affect susceptible individuals, sometimes after small doses and short exposure.
That is an uncomfortable answer, and it is the accurate one. Anyone who tells you persistent symptoms are impossible is overstating the evidence. So is anyone who tells you they are common.
The same review offers useful guidance before you start. Men with a history of depression, sexual dysfunction or fertility problems warrant individual assessment before a 5-alpha reductase inhibitor is prescribed.
Is topical or spray finasteride safer than oral?
Topical finasteride is applied to the scalp rather than swallowed, to act on hair follicles while limiting how much reaches the bloodstream. Online it is often presented as a way to keep the hair without any sexual risk.
That goes further than the evidence supports. Topical finasteride does reach the bloodstream and does lower DHT throughout the body, just less than the tablet. Lower exposure suggests lower risk, not absent risk, and the topical trials are smaller and shorter.
How the formulations compare
Oral finasteride, 1 mg daily for hair loss. Pooled trial data give a relative risk of sexual dysfunction of 1.66. What remains unclear is why a minority report lasting symptoms.
Oral finasteride, 5 mg daily for prostate enlargement. Sexual side effects are reported more often than at the 1 mg dose. What remains unclear is how much of that difference is dose alone.
Oral dutasteride, 0.5 mg daily. Relative risk 1.37, but the confidence interval crossed 1, so the result was not significant. Fewer trials exist, so the estimate is less certain.
Topical finasteride, applied to the scalp. Systemic DHT suppression is lower, so risk is expected to be lower. Long-term data are limited compared with the oral drug.
If you are considering switching to topical specifically because of sexual symptoms, that is a conversation worth having with the doctor who prescribed it, not a change to make on your own.
Why the evidence looks contradictory
Read any forum on this and you will see men insisting side effects always reverse, others describing lasting harm, and doctors quoted on both sides. The confusion has a genuine scientific basis rather than being simple misinformation.
A 2026 study published in the Journal of Dermatological Treatment examined adverse event reports submitted to the United States Food and Drug Administration from 2006 to 2024. Sexual adverse events were reported disproportionately more often for finasteride 1 mg than for dutasteride 0.5 mg, the more potent drug. If DHT suppression were the whole story, the more potent drug should generate more reports, not fewer.
The authors also noted that reporting rose sharply from 2012, the year a foundation began formally raising awareness of post-finasteride syndrome. Their conclusion was that the pattern could be attributed to the nocebo effect, where expectation of a side effect contributes to experiencing it.
So one 2026 analysis argues expectation drives much of the reporting, while another 2026 cohort finds a measurable increase in risk. Both can hold. Expectation can amplify symptoms that also have a physical component. Neither cancels the other, which is why the argument never resolves.
What this means in practice is straightforward. Your symptoms are not dismissed as imaginary, and they are also not proof of permanent injury. They are a reason for assessment.
What I see in my clinic
In my clinic at Curewell Therapies, men taking finasteride usually arrive after seeing a dermatologist and having already decided the drug is responsible. Across 30 years of practice, three patterns stand out.
The first is timing. Men who describe a change within days of the first tablet, before the drug has meaningfully altered hormone levels, are often describing anxiety about the medicine rather than its pharmacology. Men who describe a gradual change over several months are a different conversation entirely.
The second is that the examination frequently finds something else. High blood pressure, disturbed sleep, untreated blood sugar and heavy alcohol use all affect erections, and none stop mattering because a man takes finasteride. Attributing everything to the tablet is the most common way a treatable cause gets missed.
The third is that once a man starts watching his erections closely, the watching itself becomes part of the problem. Performance anxiety builds quickly, and it responds to being named and addressed directly.
These are anonymised, composite observations from clinical practice rather than published findings, and individual cases vary.
What to do if this is happening to you
Start by not stopping the drug on your own. Speak to whoever prescribed it, because the decision involves your hair as well as your erections and both matter.
Write down when the tablets started and when the symptoms started. That timeline does more diagnostic work than any single test.
Expect a proper assessment rather than an immediate prescription. A reasonable workup includes blood pressure, blood sugar, a lipid profile and hormone testing, and where the history points that way, an ultrasound study of penile blood flow. The tests recommended for erectile dysfunction are set out separately.
Ask whether a lower dose, a topical formulation, or a supervised break suits your case. These are legitimate options a prescribing doctor should discuss.
If an erection problem persists once the drug question is settled, it is treatable on its own terms. Options range from lifestyle and vascular management through to medication and non-surgical approaches, covered on our page on erectile dysfunction treatment.
When to see a doctor
Some presentations need assessment quickly, whether or not you take finasteride. Arrange to see a doctor if any of the following apply.
The change was sudden and complete rather than gradual, particularly if you have high blood pressure, diabetes, high cholesterol or a family history of heart disease. Erectile dysfunction can be an early vascular warning sign.
There is pain, curvature, a lump in the shaft, or an erection that will not subside.
Symptoms have continued for more than three months after stopping the drug.
Mood has changed alongside the sexual symptoms, including low mood, loss of motivation or disturbed sleep.
You are also trying to conceive, since semen quality deserves separate assessment.
Erectile dysfunction is one of the earliest signals of vascular disease in men, often appearing years before cardiac symptoms. A hair-loss tablet in your history is not a reason to skip that evaluation.
Frequently asked questions
Can finasteride cause erectile dysfunction permanently?
For most men, no. Sexual side effects usually settle within weeks to a few months of stopping the drug. A small group reports symptoms lasting longer, described as post-finasteride syndrome. Current research can neither confirm nor rule out that condition, so honest counselling matters more than reassurance.
How long does it take for erections to recover after stopping finasteride?
Most men notice improvement within a few weeks. Reported recovery ranges from several days to a few months, and the drug clears the body long before hormone levels fully settle. If nothing has changed after three months, arrange an assessment rather than continuing to wait.
Can I take an ED tablet while I am still on finasteride?
There is no direct interaction between finasteride and the common erectile dysfunction tablets, and the two are often prescribed together. That said, adding a second drug without working out why the erection changed can hide a problem worth finding. Ask your doctor to review the cause first.
Does finasteride lower testosterone?
No, it usually raises it slightly. Finasteride blocks the enzyme that converts testosterone into dihydrotestosterone, so circulating testosterone often rises a little while DHT falls sharply. This is why a low testosterone reading rarely explains sexual symptoms in men taking the drug, and why testing matters.
Is it true that 1 percent of men get irreversible ED from finasteride?
That figure circulates widely online but does not come from any study I can trace. The pooled trial data describe a raised relative risk of sexual side effects, not a fixed rate of permanent harm. Treat precise-sounding percentages from forums with caution, including reassuring ones.
Can finasteride stop morning erections?
Some men report fewer morning erections after starting finasteride. Morning erections depend on sleep quality and on blood flow and nerve supply working normally, so losing them can also point to sleep problems, stress or a vascular cause. That makes them a signal worth investigating properly.
Should I stop finasteride if I notice a change?
Speak to the doctor who prescribed it before stopping. Sexual symptoms that start soon after beginning the drug are worth taking seriously, but stopping without review leaves both the hair loss and the cause unaddressed. A short assessment usually clarifies whether the drug is responsible.
References
Lee S, Lee YB, Choe SJ, Lee WS. Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis. Acta Dermato-Venereologica. 2019;99(1):12-17. https://pubmed.ncbi.nlm.nih.gov/30206635/
Pereira AFJR, Coelho TOA. Post-finasteride syndrome. Anais Brasileiros de Dermatologia. 2020;95(3):271-277. https://pubmed.ncbi.nlm.nih.gov/32317131/
Gupta AK, Talukder M, Williams G, Bamimore MA. Oral finasteride use and sexual adverse events: signal detection from disproportionality analyses of data from the United States Food and Drug Administration Adverse Event Reporting System. Journal of Dermatological Treatment. 2026;37(1):2611703. https://pubmed.ncbi.nlm.nih.gov/41524216/
About the author
Dr. Sudhir Bhola is one of the top sexologists in India and a leading Sexologist Doctor, as well as the founder of Curewell Therapies. He is a member of ISSM, ESSM, AASECT and NAMA, with more than 30 years of clinical experience treating men's sexual health conditions. He practises across clinics in Delhi NCR and sees patients nationally and internationally.
